Health
Researchers to test monoclonal antibodies against COVID-19 – Mirage News
Getty Images “We need a treatment that is effective,” said infectious disease physician Ann Collier, who is leading the trial at UW Medicine. UW…
UW Medicine is one of a network of U.S. sites testing a new treatment for COVID-19 that involves monoclonal antibodies, which are intended to provide immediate antiviral activity that lasts several weeks.
The drug is part of the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial, sponsored by the National Institute of Allergy and Infectious Diseases. The trial is also receiving support from Operation Warp Speed, the U.S. government’s multi-agency effort to help end the pandemic….
-
General20 hours agoQueensland government expands youth justice laws, David Crisafulli tells UN critics ‘you don’t control me’
-
General23 hours agoRestaurants on the brink as business failures plateau
-
General19 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore
-
General23 hours agoRegional house price growth outstrips capital cities